How long is reconstituted retatrutide stable?

No regulator-reviewed stability data are published for retatrutide outside Lilly's trials, so there is no sourced in-use period to show. Claims on seller pages are not FDA-reviewed. The tool computes a date only from a number of days you supply.

How is the discard-by date calculated?

Start date plus N calendar days. For example, Oct 19, 2026 plus 28 days is Nov 16, 2026. The tool also shows days left from today.

Can a product be put back in the refrigerator?

There is no published guidance for research products. For approved brands, follow the label: some allow returning to refrigeration, and the room-temperature total still counts.

Is retatrutide FDA approved?

No. As of Oct 19, 2026 retatrutide is investigational. Lilly reported Phase 3 results in 2026 and said it plans to submit to the FDA in the first quarter of 2027. It is legally available only to participants in Lilly clinical trials.

Retatrutide Storage & Discard-By Date Calculator

Short answer

Discard-by date = start date + N days. Retatrutide has no published in-use or room-temperature period because it is not an approved product, so N must come from you. Example: N = 28 from Oct 19, 2026 gives Nov 16, 2026. Arithmetic as of Oct 19, 2026; GLP Ladder never invents stability data.

Discard by: Nov 16, 2026
Days left from today: 28 (from Oct 19, 2026)

No FDA-reviewed in-use or room-temperature period is published for this product. Enter a number of days from a source you trust.

Math, parameters and sources: model card.

Label in-use periods

No regulator-reviewed in-use or room-temperature period exists for retatrutide, because it has not been approved anywhere. Stability claims on seller pages are not FDA-reviewed. The calculator therefore only adds a number of days you supply to a start date.

All labels also say not to freeze the product and to protect it from light and heat. When in doubt, the carton insert for your exact presentation is the authority.

Frequently asked questions

How long is reconstituted retatrutide stable?: No regulator-reviewed stability data are published for retatrutide outside Lilly's trials, so there is no sourced in-use period to show. Claims on seller pages are not FDA-reviewed. The tool computes a date only from a number of days you supply.
How is the discard-by date calculated?: Start date plus N calendar days. For example, Oct 19, 2026 plus 28 days is Nov 16, 2026. The tool also shows days left from today.
Can a product be put back in the refrigerator?: There is no published guidance for research products. For approved brands, follow the label: some allow returning to refrigeration, and the room-temperature total still counts.
Is retatrutide FDA approved?: No. As of Oct 19, 2026 retatrutide is investigational. Lilly reported Phase 3 results in 2026 and said it plans to submit to the FDA in the first quarter of 2027. It is legally available only to participants in Lilly clinical trials.

Sources

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market. Eli Lilly and Company (via PR Newswire), Aug 12, 2026. Accessed Oct 19, 2026.
Warning Letter: Peak Performance Peptides, MARCS-CMS 735127. U.S. Food and Drug Administration, Aug 24, 2026. Accessed Oct 19, 2026.
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial. Eli Lilly and Company (via PR Newswire; also investor.lilly.com), May 21, 2026. Accessed Oct 19, 2026.

Printed from GLP Ladder. To recreate this result, open https://glpladder.com/tools/retatrutide-storage/

Questions for my clinician